There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Boston Scientific (BSX), Hologic (HOLX) and Teladoc (TDOC) with bullish sentiments.
Boston Scientific (BSX)
In a report released today, Cecilia Furlong from Morgan Stanley maintained a Buy rating on Boston Scientific, with a price target of $51.00. The company’s shares closed last Wednesday at $44.24, close to its 52-week high of $44.63.
According to TipRanks.com, Furlong is a 5-star analyst with an average return of 65.7% and a 82.1% success rate. Furlong covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Shockwave Medical, and Abbott Labs.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Boston Scientific with a $46.92 average price target, representing a 7.0% upside. In a report released yesterday, Piper Sandler also maintained a Buy rating on the stock with a $51.00 price target.
See today’s analyst top recommended stocks >>
Hologic (HOLX)
In a report released today, Richard Newitter from Leerink Partners maintained a Buy rating on Hologic, with a price target of $85.00. The company’s shares closed last Wednesday at $72.40.
According to TipRanks.com, Newitter is a 5-star analyst with an average return of 28.6% and a 71.1% success rate. Newitter covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Zimmer Biomet Holdings, and Organogenesis Holdings.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Hologic with a $91.50 average price target, representing a 25.0% upside. In a report issued on April 27, Raymond James also maintained a Buy rating on the stock.
Teladoc (TDOC)
In a report released today, Donald Hooker from KeyBanc maintained a Buy rating on Teladoc, with a price target of $220.00. The company’s shares closed last Wednesday at $186.31.
According to TipRanks.com, Hooker is a 5-star analyst with an average return of 17.2% and a 69.9% success rate. Hooker covers the Technology sector, focusing on stocks such as Veeva Systems, American Well, and Phreesia.
Teladoc has an analyst consensus of Moderate Buy, with a price target consensus of $257.30, representing a 38.1% upside. In a report issued on April 15, Needham also initiated coverage with a Buy rating on the stock with a $235.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TDOC:
